The Handbook of Psychopharmacology Trials: An Overview of Scientific, Political, and Ethical ConcernsMarc Hertzman, Douglas E. Feltner NYU Press, 1997 - 454 sider Each year pharmaceutical companies invest billions of dollars in clinical trials of drugs used for the treatment of central nervous system diseases. Due to enormous progress in basic pharmaceutical research in recent years, controlled tests of new medications are flourishing and these trials have rapidly become an intense focus of practical medical research. |
Inni boken
Resultat 1-5 av 38
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Innhold
One The Importance of Clinical Trials for Central | 3 |
Two Ethical Considerations of Federal Guidelines | 23 |
Central | 46 |
Five CNS Clinical Drug Trials and Women | 100 |
Six The Placebo Effect in Drug Trials and | 123 |
Seven The Clozapine Story | 137 |
Eight Clinical Trials of Typical Neuroleptics | 157 |
Nine Pharmacologic Treatment of Depression | 192 |
Ten Methodological Issues in Pharmacotherapy | 213 |
Eleven Conducting Clinical Drug Trials in | 246 |
Twelve Assessing Pharmacotherapy in Insomnia | 268 |
Separate | 315 |
Fifteen What Are We Doing? A Closer Look at | 348 |
Sixteen New Molecules and New Therapies | 377 |
425 | |
Vanlige uttrykk og setninger
Referanser til denne boken
Discovering Addiction: The Science and Politics of Substance Abuse Research Nancy D. Campbell Begrenset visning - 2007 |